Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14374354 | 1.00 | GPBAR1 (0.80) | GPBAR1PRKCD | |
| SCHEMBL14374392 | 1.00 | GPBAR1 (0.80) | GPBAR1PRKCD | |
| SCHEMBL17281331 | 0.90 | GPBAR1 (0.83) | GPBAR1PRKCD | |
| SCHEMBL15374775 | 0.89 | GPBAR1 (0.81) | GPBAR1PRKCD | |
| Dihydrobetulinic Acid SCHEMBL14071702 | 0.89 | GPBAR1 (1.00) | GPBAR1PRKCD | |
| Dihydrobetulinic Acid SCHEMBL23284046 | 0.89 | GPBAR1 (1.00) | GPBAR1PRKCD | |
| Dihydrobetulinic Acid SCHEMBL14837675 | 0.89 | GPBAR1 (1.00) | GPBAR1PRKCD | |
| Dihydrobetulinic Acid SCHEMBL16512008 | 0.89 | GPBAR1 (1.00) | GPBAR1PRKCD | |
| Dihydrobetulinic Acid SCHEMBL14086957 | 0.89 | GPBAR1 (1.00) | GPBAR1PRKCD | |
| Dihydrobetulinic Acid SCHEMBL3781854 | 0.89 | GPBAR1 (1.00) | GPBAR1PRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070232577-A1 | Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin | ADVANCED LIFE SCIENCES, INC. (US) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232577-A1 | Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin | BET1, PGGT1B, BRCA1 | GPBAR1 225/4885PRKCD 1907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.